Current Innovative Research with Practical Applications
Translating discovery into diagnostics that change lives
Active
Liquid Biopsy Integration
Dr. Sarah Chen, MD, PhD
Developing standardized protocols for ctDNA analysis in solid tumor monitoring. Our pilot program has reduced time-to-treatment decisions by 40% in lung cancer cases.
340Patients Enrolled
40%Faster Decisions
Active
AI-Assisted Gleason Grading
Dr. James Okonkwo, MD
Deep learning models trained on 50,000+ prostate biopsies to assist pathologists in consistent Gleason scoring. FDA breakthrough device designation pending.
94.2%Concordance
12minTime Saved/Case
Recruiting
Digital Neuropathology Consortium
Dr. Maria Santos, MD, PhD
Multi-center validation of whole-slide imaging for CNS tumor classification. Opening remote consultation pathways for underserved regions.
8Institutions
1,200Cases Reviewed
Published
Rapid Sepsis Pathogen ID
Dr. Robert Kim, MD
Metagenomic sequencing from positive blood cultures achieving species-level identification in 6 hours vs. 48+ hours with traditional methods.
6hrsTurnaround
89%Accuracy